Welcome to Drug Target Review. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Oncology
  • AI
  • Topics
    • Back to parent navigation item
    • Topics
    • Technology
    • Resources
    • Diseases
    • Drugs and therapies
    • Research and development
    • Tools and techniques
    • Business
  • Webinars
  • Whitepapers
  • Reports
  • Home
  • News
  • Oncology
  • AI
  • Topics
      • Technology
      • Resources
      • Diseases
      • Drugs and therapies
      • Research and development
      • Tools and techniques
      • Business
    • Cell,Culture,With,Multichannel,Pipettes
      Designing targeted assays for clinical success from the start
    • Medical,Scientist,Loading,Samples,In,Robot,Machine,For,Biochemical,Automatic
      Discovery is changing – and automation leads the way
    • Image
      World ADC 2026: where antibody-drug conjugates are heading
  • Webinars
  • Whitepapers
  • Reports
  • More navigation items

A to Z subjects

Find stories by subject. Use the A-Z options to view other subjects.

  • A to Z subjects
  • A to Z contributors
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • 0-9
  • All
V
  • Vaccine Development
  • Vaccines
  • Valérie Dutoit (the UNIGE Faculty of Medicine’s Department of Medicine and Translational Research Centre in Onco-Haematology)
  • Vall d'Hebron University Hospital
  • Van Andel Institute
  • Vanderbilt University Medical Center
  • Vanitha Margan (Global Product Manager for Bio-Plex Multiplex Immunoassays at Bio-Rad Laboratories)
  • Variant Bio
  • Vascular Dementia
  • vascular disease
  • VCU Massey Comprehensive Cancer Center
  • Vedanta Biosciences
  • Veronica DeFelice (Director of Biologics at Sapio Sciences)
  • Veronika Šlachtová (postdoctoral researcher at IOCB Prague)
  • Veterans Affairs (VA) Million Veteran Program (MVP)
  • Veterinary
  • VHIO’s Prostate Cancer Group
  • Victoria Goldenshtein
  • Vincenzo Gioia
  • Viraj Mehta (Associate Research Scientist - Sai Life Sciences)
  • viral hepatitis
  • Virginia Tech
  • Virginia Tech Carilion School of Medicine and Research Institute (VTC)
  • Virginia University
  • Virginia-Maryland College of Veterinary Medicine
  • Virtual tissue technology
  • Vish Srivastava (Co-Founder & CEO of Century Health)
  • Vishal Mehta (Founder of Ubuntu Research)
  • vision impairment.
  • Vitalant
  • VitalTE
  • Vitiligo
  • Vittoria
  • Vortex
  • Topics
  • Technology
  • Resources
  • Diseases
  • Drugs and therapies
  • Research and development
  • Tools and techniques
  • Business
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
The trusted voice in drug discovery
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 Drug Target Review

Site powered by Webvision Cloud